Shanghai Fosun Pharmaceutical (Group) (SFOSF) Stock Price, News & Analysis

Company Overview

Shanghai Fosun Pharmaceutical (Group) Co., Ltd. develops, manufactures, and sells pharmaceutical products in Mainland China and internationally. It operates in five segments: Pharmaceutical Manufacturing, Medical Devices and Medical Diagnosis, Healthcare Service, Pharmaceutical Distribution and Retail, Other Business segments. The company offers pharmaceutical products in the areas of tumor, immune modulation, anti-infection, API's and intermediate, metabolism, alimentary system, cardiovascular and central nervous system. It also provides medical devices and diagnostic products. In addition, the company offers health care and hospital management services, and investment management services. Further, it engages in retail and wholesale distribution of medicines. Shanghai Fosun Pharmaceutical (Group) Co., Ltd. was founded in 1994 and is based in Shanghai, China.

Key Stats

• Today's Range: $1.95 to $1.95
• 50-Day Range: $1.90 to $2.01
• 52-Week Range: $1.50 to $2.24
• Volume: N/A
• Average Volume: 5,080 shs
• Market Capitalization: N/A
• P/E Ratio: 1.66
• Dividend Yield: 13.88%
• Price Target: N/A
• Consensus Rating: N/A

Shanghai Fosun Pharmaceutical (Group) Stock Analysis - MarketRank™

Shanghai Fosun Pharmaceutical (Group) scored higher than 33% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: N/A
• Analyst Rating: N/A

Consensus Rating

There is not enough analysis data for Shanghai Fosun Pharmaceutical (Group).

Earnings and Valuation

• Score: 1.3 / 5
• Proj. Earnings Growth: N/A

Price to Earnings Ratio vs. the Market

The P/E ratio of Shanghai Fosun Pharmaceutical (Group) is 1.66, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 21.76.

Price to Earnings Ratio vs. Sector

The P/E ratio of Shanghai Fosun Pharmaceutical (Group) is 1.66, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 22.51.

Short Interest

• Score: 4.0 / 5
• Short Interest Level: Healthy

Percentage of Shares Shorted

Short Interest Ratio / Days to Cover

Shanghai Fosun Pharmaceutical (Group) has a short interest ratio ("days to cover") of 0, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in Shanghai Fosun Pharmaceutical (Group) has recently decreased by 51.07%, indicating that investor sentiment is improving significantly.

Dividend

• Score: 1.7 / 5
• Dividend Strength: Weak

Dividend Yield

Shanghai Fosun Pharmaceutical (Group) pays a meaningful dividend of 1.21%, higher than the bottom 25% of all stocks that pay dividends.

Dividend Growth

Shanghai Fosun Pharmaceutical (Group) does not have a long track record of dividend growth.

Dividend Coverage

The dividend payout ratio of Shanghai Fosun Pharmaceutical (Group) is 23.08%. This payout ratio is at a healthy, sustainable level, below 75%.

Sustainability and ESG

• Score: N/A
• Environmental Score: N/A

Percentage of Shares Shorted

Short Interest Ratio / Days to Cover

Shanghai Fosun Pharmaceutical (Group) has a short interest ratio ("days to cover") of 0, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in Shanghai Fosun Pharmaceutical (Group) has recently decreased by 51.07%, indicating that investor sentiment is improving significantly.

News and Social Media

• Score: 2.8 / 5
• News Sentiment: N/A

News Sentiment

Shanghai Fosun Pharmaceutical (Group) has a news sentiment score of 1.00. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.84 average news sentiment score of Medical companies.

News Coverage This Week

MarketBeat has tracked 1 news article for Shanghai Fosun Pharmaceutical (Group) this week, compared to 0 articles on an average week.

Company Ownership

• Score: 0.0 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, Shanghai Fosun Pharmaceutical (Group) insiders have not sold or bought any company stock.

Percentage Held by Institutions

Only 4.64% of the stock of Shanghai Fosun Pharmaceutical (Group) is held by institutions.

SFOSF Stock Analysis - Frequently Asked Questions

How have SFOSF shares performed this year?

Shanghai Fosun Pharmaceutical (Group)'s stock was trading at $1.8003 at the beginning of 2025. Since then, SFOSF shares have increased by 8.0% and is now trading at $1.9450.
View the best growth stocks for 2025 here.

How do I buy shares of Shanghai Fosun Pharmaceutical (Group)?

Shares of SFOSF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Medical
• Industry: Drug Manufacturers - Specialty & Generic
• Sub-Industry: N/A
• Current Symbol: OTCMKTS:SFOSF
• CIK: N/A
• Web: www.fosunpharma.com
• Phone: 86-21-3398-7000
• Fax: N/A
• Employees: 40,370
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): N/A
• Trailing P/E Ratio: 1.66
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: N/A